Johnson & Johnson Set To Receive EU Approval Of $21.3 Billion Synthes Deal -Reuters
March 15 2012 - 4:02PM
Dow Jones News
Johnson & Johnson (JNJ) is set to receive European Union
approval for its $21.3 billion purchase of Swiss medical device
company Synthes Inc. (SYST.VX) after making concessions related to
dominance in the trauma products market, Reuters reported Thursday,
citing a person familiar with the situation.
Approval could take place before an April 26 EU deadline,
Reuters reported.
Full story at
http://www.reuters.com/article/2012/03/15/jj-synthes-eu-idUSL5E8EF6LX20120315
-Dow Jones Newswires; 212-416-2900